Company Filing History:
Years Active: 1995-1999
Title: Friedrich Elsinger: Innovator in Blood Product Technology
Introduction
Friedrich Elsinger is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of blood product technology, holding a total of 3 patents. His work focuses on methods that enhance the safety and efficacy of blood products.
Latest Patents
Elsinger's latest patents include innovative methods for producing blood products that are safe from infectious agents. One of his key inventions is a blood product, exclusive of albumin, that is inactivated relative to infectious agents. This blood product conforms to a total virus reduction factor of at least 40 and has a biological activity of at least 50%, based on its activity prior to the inactivation of infectious agents. Additionally, he has developed a method for determining the virus inactivation capacity of a viral inactivation step. This method involves spiking a biological product with a virus multiple times during the viral inactivation step to calculate a virus reduction factor.
Career Highlights
Friedrich Elsinger is associated with Immuno Aktiengesellschaft, where he applies his expertise in blood product technology. His career is marked by a commitment to improving the safety of blood products through innovative methods and technologies.
Collaborations
Elsinger has collaborated with notable colleagues in his field, including Johann J. Eibl and Yendra Linnau. Their combined efforts contribute to advancements in blood safety and efficacy.
Conclusion
Friedrich Elsinger's work in blood product technology exemplifies innovation and dedication to public health. His patents and collaborations reflect a commitment to enhancing the safety of blood products, making a significant impact in the medical field.